PAC Partners is proud to be Australia’s leading provider of investment banking services to the cannabis sector. PAC Partners bridges the gap in Australian equity capital markets for exciting emerging companies seeking capital, with most global investment banks servicing companies within the ASX100 only.

PAC Partners offers a broad suite of services across its advisory teams, including ECM, M&A, institutional-grade research, and equities trading & execution. With corporate offices in Melbourne and Sydney and a team of highly experienced market specialists, PAC has been delivering market-leading outcomes for its clients.

PAC Partners has advised on the IPOs and provided services to several of Australia’s largest medicinal cannabis companies, including Althea (ASX:AGH), Cann Group (ASX:AC8), AusCann (ASX:AC8), Bod Australia (ASX:BDA) and Emerald Clinics (ASX:EMD). In the cannabis sector, PAC Partners has raised more than A$200 million from investors.

With a strong track record in dealing with cannabis business, as well as agribusiness, technology, life science and the energy sector, PAC Partners will be joining the Cannabis Oceania stream at Prohibition Partners LIVE to share the insights the company has gained as a leading independent equities provider in Australia.

Join Prohibition Partners LIVE on 22–23 June to discover the latest developments in the European cannabis sector, learn from our world-renowned speakers, and engage with our network of industry-leading professionals who are pushing boundaries in the cannabis space.